The history of ureteral stents begins with Charles Thomas Stent, after whom the stent is named.
Dr Stent was a dentist in London who developed a material in the 1850s that he used to …

Objective To summarise the current state of research into spermatogonial stem cell (SSC)
therapies with a focus on future directions, as SSCs show promise as a source for preserving …

Objective We investigated systematic review automation tool use by systematic reviewers,
health technology assessors and clinical guideline developerst. Study design and setting An …

Purpose: Medical schools are increasingly aware of the ways in which physician empathy
can have a profound impact on patients’ lives and have developed humanities initiatives to …

Purpose: Holmium laser enucleation of the prostate has proven to be efficacious and safe for
the treatment of benign prostatic hyperplasia. New laser technologies, such as the MOSES…

Purpose Partial nephrectomy (PN) for early stage renal cancer preserves renal function
better than radical nephrectomy (RN) and is generally considered oncologically similar. The …

Background Little is known about how benign prostatic hyperplasia (BPH) develops and
why patients respond differently to medical therapy designed to reduce lower urinary tract …

Introduction Radical cystectomy (RC) is a challenging procedure with significant morbidity,
though remains the standard of care treatment for many patients with bladder cancer. There …

Background With the heterogeneous distribution of novel surgical technologies and variable
physician training, there is a need to re-evaluate contemporary outcomes of percutaneous …

Ureteral stents: the good the bad and the ugly : Current Opinion in Urology Ureteral stents: the
good the bad and the ugly : Current Opinion in Urology Log in or Register Subscribe to …